Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,431.00
Bid: 1,434.00
Ask: 1,435.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.07%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,431.00
SMSN Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transactions with Affiliated Companies

30 Apr 2024 08:10

RNS Number : 5674M
Samsung Electronics Co. Ld
30 April 2024
 

Transaction with Affiliate Company

 

 

Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) on April 30, 2024

announced that its Board of Directors has authorized following related-party transaction

with an affiliated company.

 

Trademark License Agreement

- Grant trademark license to Samsung Biologics

 

□ Major Transaction Terms

Transaction Item

License fee for use of trademark

Transaction Date

May 10, 2024

Transaction Period

February 1, 2024-January 31, 2027

Transaction Value

KRW 28,244 million

(total transaction value: KRW 28,244 million)

Other information

- The transaction date is the date on which the trademark license agreement with

 Samsung Biologics will be executed.

- Transaction period is the term of the trademark license agreement.

- The transaction value is an estimate and may change in accordance with

 Samsung Biologics revenue.

* The license fee is set at 0.5% of Samsung Biologics' revenue (excluding

revenue or purchases not related to the use of trademark) and shall be paid

every year during the transaction period.

Other Information:

ž Number of Independent Directors Present at the BOD Meeting: 6/6

ž Attendance of Audit Committee: Y

 

※ This disclosure is in accordance with the Korean Fair Trade Act, which mandates that a company must disclose

its financial and real estate transactions in the event the value of such a transaction is greater than or equal to

KRW 10 billion and the counterparty is a financial affiliate of the party required to make the disclosure.

 

Transaction with Affiliate Company

 

Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) on April 30, 2024

announced that its Board of Directors has authorized following related-party transaction

with an affiliated company.

 

Trademark License Agreement

- Grant trademark license to Samsung Bioepis

 

□ Major Transaction Terms

Transaction Item

License fee for use of trademark

Transaction Date

May 10, 2024

Transaction Period

February 1, 2024 - January 31, 2027

Transaction Value

KRW 12,843 million

(total transaction value: KRW 12,843 million)

Other information

- The transaction date is the date on which the trademark license agreement with

 Samsung Bioepis will be executed.

- Transaction period is the term of the trademark license agreement.

- The transaction value is an estimate and may change in accordance with

 Samsung Bioepis revenue.

* The license fee is set at 0.5% of Samsung Bioepis' revenue (excluding

revenue or purchases not related to the use of trademark) and shall be paid

every year during the transaction period.

Other Information:

ž Number of Independent Directors Present at the BOD Meeting: 6/6

ž Attendance of Audit Committee: Y

 

※ This disclosure is in accordance with the Korean Fair Trade Act, which mandates that a company must disclose

its financial and real estate transactions in the event the value of such a transaction is greater than or equal to

KRW 10 billion and the counterparty is a financial affiliate of the party required to make the disclosure.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGZGFDNGRGDZG
Date   Source Headline
16th Feb 202110:13 amRNSReference Material for 2021 AGM
16th Feb 20219:03 amRNSTransaction with an affiliate
16th Feb 20219:02 amRNSTransaction with an affiliate
16th Feb 20218:31 amRNSCharitable Contribution
28th Jan 202110:29 amRNSShareholder Return Program for FY2021-2023
28th Jan 20219:10 amRNSYear-End Dividend for FY2020
28th Jan 20219:06 amRNS2020 4Q Earnings Release
20th Jan 20219:26 amRNSCourt Judgment Relating to Embezzlement
8th Jan 20217:56 amRNS4Q 2020 Pre-Earnings Guidance
8th Jan 20217:54 amRNSNotice of 4Q 2020 Earnings Release Schedule
1st Dec 20207:00 amRNSCharitable Contribution
1st Dec 20207:00 amRNSCharitable Contribution
30th Nov 202011:26 amRNS2020 3Q Interim Report
30th Nov 20208:51 amRNSTransaction with Affiliate Company
30th Nov 20208:45 amRNSTransaction with Affiliate Company
30th Nov 20208:40 amRNSTransaction with Affiliate Company
30th Nov 20208:39 amRNSTransaction with Affiliate Company
24th Nov 20209:32 amRNSAnnouncement of Investor Relations Event
29th Oct 20208:03 amRNSTransaction with Affiliate Company
29th Oct 20207:53 amRNSAnnouncement of Capex Plan for FY 2020
29th Oct 20207:47 amRNSQuarterly Dividend for Third Quarter 2020
29th Oct 20207:33 amRNS2020 3Q Earnings Release
8th Oct 20209:05 amRNSNotice of 3Q 2020 Earnings Release Schedule
8th Oct 20209:03 amRNS3Q 2020 Pre-Earnings Guidance
7th Sep 20207:00 amRNSSigning of Supply Contract
1st Sep 20207:00 amRNS2020 Half Year Report
30th Jul 20209:02 amRNSTransaction with Affiliate Company
30th Jul 20208:55 amRNSQuarterly Dividend for Second Quarter 2020
30th Jul 20208:42 amRNS2020 2Q Earnings Release
15th Jul 20208:20 amRNSSustainability Report 2020
7th Jul 20208:30 amRNSNotice of 2Q 2020 Earnings Release Schedule
7th Jul 20208:28 amRNS2Q 2020 Pre-Earnings Guidance
29th May 202011:02 amRNS2020 1Q Interim Report
29th May 202010:55 amRNSCorporate Governance Report FY2019
27th May 20209:00 amRNSRenewal of Property & Casualty Insurance Policy
27th May 20208:55 amRNSCharitable Contribution
29th Apr 202012:05 pmRNS2019 Business Report
29th Apr 20207:56 amRNSCharitable Contribution
29th Apr 20207:50 amRNSCharitable Contribution
29th Apr 20207:46 amRNSTransaction with Affiliate Company
29th Apr 20207:43 amRNSTransaction with Affiliate Company
29th Apr 20207:40 amRNSTransaction with Affiliate Company
29th Apr 20207:32 amRNSTransaction with Affiliate Company
29th Apr 20207:28 amRNSQuarterly Dividend for First Quarter 2020
29th Apr 20207:20 amRNS2020 1Q Earnings Release
7th Apr 20207:00 amRNSNotice of 1Q 2020 Earnings Release Schedule
7th Apr 20207:00 amRNS1Q 2020 Pre-Earnings Guidance
18th Mar 20208:35 amRNSTransaction with Affiliate Company
18th Mar 20208:19 amRNSResults of the 51st Annual General Meeting
26th Feb 20208:18 amRNSCharitable Contribution

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.